Achievement of High-quality Analgesia, Rapid Recovery With Rehabilitation in Lumber Spine Discectomy
Conditions
Keywords
erector spinae plane block modified thoracolumbar interfascial plane block perioperative analgesia lumber spine discectomy?
Brief summary
the purpose of this study is to compare of better postoperative analgesia following lumber spine discectomy
Interventions
The probe will be placed in the parasagittal plane at the level of the L3 vertebrae. The spinous process will be visualized, and the probe was moved 3 cm laterally from the midline. The erector spinae musclewill be visualized above the transverse process. The needle will be punctured in the craniocaudal direction using the in-plane technique. The needle will be directed superior to the transverse process . Then, 2 mL normal saline solution will be injected into the deep fascia of the erector spinae muscle to confirm the proper injection site. After ensuring the location of the needle, 20 mL of 0.25% bupivacaine will be administered. The same ESPB procedure will be performed on the other side. In total, 40 mL of 0.25% bupivacaine was administered
Sponsors
Zagazig University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
21 Years to 64 Years
Healthy volunteers
No
Inclusion criteria
* Written informed consent from the patient. * Physical status: ASA 1& II. * BMI = (25-30 kg/m2). * Type of operation: elective Lumbar discectomy .
Exclusion criteria
* Altered mental state. * Patients with known history of allergy to study drugs. * Advanced hepatic, renal, cardiovascular, and respiratory diseases. * Patients with chronic pain. * Patients receiving anticoagulants. * Contraindications of regional anesthesia, e.g., allergy to local anesthetics, coagulopathy, or septic focus at site of injection.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Length of hospital stay | up to 1 weak postoperative. | from the day of admission till discharge from hospital |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The time of discharge | up to 2 hours postoperative. | The time from arrival to the PACU to discharge to the ward |
| 6 minutes walk test | 24 hours postoperative | involves walking for 6 min on a 30 m walking path and measuring the distance |
| Functional reach test | 24 hours postoperative | quantifies participants' dynamic in-place standing balance control to reach distance. The distance between the starting and maximal forward reach distance beyond the participant's arm length represents the reach distance and is recorded in centimeters |
| The recovery time | up to 30 minutes postoperative. | time from discontinuation of isoflurane to first response to verbal command |
| Pain intensity | 30 minutes after the end of the surgery, as well as 3, 6, 12, and 24 hours postoperatively | 10-point NRS \[(0 = no pain, 10 = worst imaginable pain), 1 - 3: Mild pain (nagging, annoying, slightly interfering with activities of daily living (ADLs), 4 - 6: Moderate pain (significantly interfering with ADLs, 7 - 10: Severe pain (disabling, unable to perform ADLs)\] |
| Time to first call analgesia | 24 hours postoperative | — |
| Total naluphine consumption | 24 hours post-operative | — |
| Time up and go test | 24 hours postoperative | objective measure of functional disability that can be used to evaluate various activities such as standing, accelerating, walking, decelerating, and turning, which are often limited in patients with lumbar degenerative diseases |
Countries
Egypt
Outcome results
None listed